IMMX Stock Price
Immix Biopharma, Inc.
IMMX stock price is $8.51 (-2.07% on the day), giving Immix Biopharma, Inc. a market cap of $705.50M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
IMMX Stock Overview
- Price
- $8.51
- Previous close
- $8.69
- Open
- $8.60
- Market cap
- $705.50M
- P/E ratio
- -24.0
- 52-week range
- $2.31 - $15.10
- 1-year price target
- $24.57
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 40
About Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMMX | $8.51 | -2.1% | 1.36M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |